Companies: 10,795·Total market cap: $144.5T
Brain Scientific Inc.

Brain Scientific Inc.

BRSFOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$746
P/E Ratio
52W High$0.75
52W Low$0.0001

Brain Scientific Inc. (BRSF) · Income Statement

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · BRSF · as of 2026-06-09

Financial statements

Revenue · Gross Profit · Net Income
Breakdown2022-122021-122020-122019-122018-12
Revenue
Revenue$0.21M$0.27M$0.09M$0.49M$0.06M
Cost of Revenue$0.16M$0.18M$0.04M$0.39M$0.03M
Gross Profit$0.05M$0.08M$0.05M$0.10M$0.02M
Gross Margin %(computed)25.32%31.32%53.28%20.85%41.60%
Operating Expenses
R&D Expenses$0.30M$0.33M$0.21M$0.10M$0.21M
G&A Expenses$8.66M$7.37M$2.41M$0.79M$0.95M
Total Operating Expenses$9.66M$8.74M$2.82M$1.07M$1.31M
Operating Income($9.61M)($8.66M)($2.77M)($0.97M)($1.29M)
Operating Margin %(computed)-198.32%
Interest Income$0.00M$0.00M$0.00M$0.00M$0.00M
Interest Expense$3.61M$0.56M$0.03M$0.03M$0.16M
Income Before Tax($12.34M)($9.10M)($2.80M)($1.00M)($1.43M)
Income Tax Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Net Income($12.34M)($9.10M)($2.80M)($1.00M)($1.43M)
Net Margin %(computed)-205.20%
Per Share & EBITDA
EPS (Basic)$-12.95$-25.21$-8.88$-4.44$-9.72
Wtd Avg Shares0.95M0.36M0.32M0.23M0.15M
EBITDA($7.93M)($8.32M)($2.75M)($0.97M)($1.28M)
EBITDA Margin %(computed)-198.05%

Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M

Explore more Brain Scientific Inc. data

About Brain Scientific Inc. (BRSF) Income Statement

Brain Scientific Inc. (BRSF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2022, BRSF reported revenue of $0.00B, gross profit of $0.00B (gross margin 25.32%), and net income of ($0.01B) — a net profit margin of -5753.00%.

Frequently asked questions

BRSF · 4 questions

Brain Scientific Inc. (BRSF) reported revenue of $0.00B for 2022, down 19.3% year-over-year.

BRSF revenueBRSF salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09